Abstract: Twenty-five new hydroxy-and methoxy-substituted 4,6-diarylpyrimidin-2(1H)-ol (20-34) and 4,6-diarylpyrimidine-2(1H)-thiol derivatives (35-44) were synthesized from the reaction of the corresponding 1,3-diaryl-2-propene-1-one compounds (1-19) with urea or thiourea using the solid-phase microwave method. All the new synthetic compounds 
Introduction
Pyrimidines are the most important pharmacological chemical scaffolds widely present in many natural products and a basic building block of DNA and RNA. Pyrimidine derivatives have been shown to be associated with a variety of chemotherapeutic effects, including antiviral, 1−3 antitumor, 4−6 antimicrobial, 7−9 antitubercular, 10−16 and antifungal 17, 18 activities. A number of useful drugs contain pyrimidine derivatives associated with anticancer, 19−22 antimalarial, 23, 24 diuretic, 25 antibiotic, 10, 26 and antihypertensive 26, 27 pharmaceutical activities. Various pyrimidine derivatives have been synthesized from many different reagents. 10,18,20,28−34 One of the most widely used methods for the synthesis of diaryl-substituted pyrimidine-2(1H)-ol/-thiol derivatives involves starting from chalcone by cyclization with urea and thiourea. 35 Chalcones are natural compounds and important precursors for the synthesis of many biologically active compounds. This class of com- * Correspondence: yayli@ktu.edu.tr pounds is reported to possess diverse chemotherapeutic properties, such as antituberculous, 30, 36 antitumor, 37−39 and antifungal 33, 40, 41 activities. Tangeretin and nobiletin type polymethoxy chalcone derivatives are reported to exhibit highly cytotoxic activity against a variety of human cancer cell lines. 42−44 Many oxygen-and sulfurcontaining heterocyclic compounds are known for their therapeutic activities and occupy a unique place in medicinal chemistry. In the light of the wide range of biological activities observed in substituted pyrimidine, the purpose of the present study was to synthesize 25 new hydroxy-and methoxy-substituted 4,6-diarylpyrimidine-2(1H)-ol (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) ) and 4,6-diarylpyrimidine-2(1H)-thiol (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) compounds from different substituted chalcone with urea or thiourea and to test their antimicrobial and enzyme activities.
Results and discussion

Synthesis
Many classic synthetic methods of pyrimidine synthesis have been used in the literature, 28−34 although these are problematic in terms of time, yields, and harsh reaction conditions. We synthesized substituted pyrimidine-2(1H)-ol/-thiol derivatives starting from hydroxy-or methoxy-substituted chalcone and urea or thiourea using the solid-phase microwave method, a practical technique for the synthesis of substituted pyrimidine-2(1H)-ol/-thiol derivatives. We also observed 4,6-diarylypyrimidin-2(1H)-one/thione and 4,6-diaryl- is mentioned in the literature as the tautomer form of methoxy-substituted 4,6-diarylypyrimidin-2(1H)-one, 45 but no spectral data are given. The structures of compounds 20-44 were identified by means of 1 H NMR, 13 C/APT-NMR, 1 H-1 H COSY, UV-Vis, FT-IR, LC-MS/MS, and LC-MS/TOF spectroscopic data, which were consistent with the proposed structure. The infrared (IR) spectra of these pyrimidine compounds showed the presence of a weak absorption band in the region of ∼3380 and ∼ 3100 cm −1 due to a -OH and hydrogenbonded -OH group, indicating the transformation of carbonyl functionality into cyclic pyrimidines. The 13 C NMR result gave the heterocyclic aromatization ring. The 1 H and 13 C NMR spectra of compounds 20-44, particularly H5-, showed peaks at δ H 7.7-8.0 (1H, bs) and C 5 at δ C 107-117 ppm, an indication of pyrimidine ring systems. 45 The mass spectral data of pyrimidine compounds are illustrated in the experimental section.
α -Glucosidase inhibitory activity of compounds 20-44
All the new synthetic compounds 
Synthesis of hydroxy-and methoxy-substituted 4,6-diarylpyrimidin-2(1H)-ol (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) , and 4,6-diarylpyrimidine-2(1H)-thiol derivatives (35) (36) (37) (38) (39) (40) (41) (42) (43) (44) . 
Antimicrobial activity of compounds 20-44
All the synthesized compounds (20-44) with concentrations ranging from 10.000 to 18.200 µ g/mL, were tested against gram-negative, gram-positive, and antifungal bacteria for antimicrobial activity using a known method. 51, 52 Ampicillin, streptomycin, and fluconazole were used as standards. Table 3 .
Experimental
Materials and equipment
All starting chemical reagents (methoxy-and hydroxy-substituted acetophenone, methoxy-and hydroxysubstituted benzaldehyde, urea, thiourea, Celite, AlCl 3 , sodium hydroxide, and acetic acid used in the synthesis were high grade commercial products purchased from Aldrich, Fluka, or Sigma and were used without further purification. The solvents (n-hexane, chloroform, ethyl acetate, methanol, diethyl ether, and dimethyl sulfoxide) used were either analytical grade or bulk solvents distilled before use.
Thin-layer chromatography (TLC) and column chromatography were performed on Merck precoated 60
Kieselgel F 254 analytical aluminum acidic plates and silica gel 60 (0.040-0.063 mm), respectively. All reactions were monitored using TLC. A Milestone microwave (MW) oven was used for solid-phase MW reactions. FT-IR, KBr (4000-400 cm −1 ) spectrometer. Melting points were determined using a Thermo-var apparatus - fitted with a microscope and are uncorrected. UV-Vis absorbance measurements and spectral analyses were carried out on a Unicam UV2-100 at 25 • C.
Synthesis
General method for the synthesis of substituted 1,3-diaryl-2-propene-1-one (1-19)
1,3-Diaryl-2-propene-1-one derivatives (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) were prepared according to the procedure described elsewhere in the literature. 53−61 Equimolar quantities of substituted acetophenone (10 mmol) and substituted benzaldehyde (10 mmol) in ethanol (10 mL) were stirred at 0-5 • C for 30 min. Sodium hydroxide (40%, 4 mL) was then added dropwise. Stirring was continued for 12 h at room temperature and the reactions were stopped after TLC monitoring. The reaction mixture was poured into crushed ice and acidified if necessary with 6 N HCl. The precipitated solid mass was filtered, washed with water, and crystallized from ethanol to give white, orange, or yellow products purified by column chromatography if necessary.
General method for the synthesis of substituted 4,6-diaryl-pyrimidine-2-ol or 4,6-diarylpyrimidine-2-thiol (20-44)
Methoxy-and hydroxy-substituted 1,3-diaryl-2-propene-1-one (0.004 mol each) and urea or thiourea (0.004 mol)
were dissolved in chloroform (15 mL) and uniformly adsorbed on the surface of Celite-AlCl 3 (3 g, 5:2 ratio, each) in a Pyrex round-bottomed flask. The solvent was evaporated under vacuum. The adsorbed material was transferred to a Pyrex tube (2 cm diameter, 30 mL) and inserted inside the Milestone MW oven. The mixtures were heated using a fixed power of 600 W for 10 min at 85
• C. The brownish crude reaction mixture was dissolved in methanol (3 × 15 mL) and then neutralized with 2 N HCl and filtered off. The eluate was evaporated and the residue dissolved in water (50 mL) and then extracted with chloroform (3 × 30 mL) to
give a crude mixture. This was purified by column chromatography over silica using hexane (50 mL) and a hexane-diethyl ether solvent mixture with a gradient of 9:1, 4:1, and 3:1 ratio (100 mL each) to elicit the pure corresponding products 
4-(4-Hydroxyphenyl)-6-phenylpyrimidin-2-ol: (21)
Yield: 36%, mp = 150-dec 281.38 (100).
4-(4-Hydroxyphenyl)-6-(3-methoxyphenyl)pyrimidin-2-ol (24)
Yield: 51%, mp = 177-179 
4-(2-Methoxyphenyl)-6-(3-methoxyphenyl)pyrimidin-2-ol (26)
Yield: 42%, mp = 127-129 
4-(2-Methoxyphenyl)-6-(2-methoxyphenyl)pyrimidin-2-ol (27)
Yield: 36%, mp =181-184 
4-(2-Methoxyphenyl)-6-(4-methoxyphenyl)pyrimidin-2-ol (28)
Yield: 48%, mp =137-139 
4-(3-Methoxyphenyl)-6-(4-methoxyphenyl)pyrimidin-2-ol (29)
Yield: 30%, mp = 153-155 
4,6-Bis(4-methoxyphenyl)pyrimidin-2-ol (30)
Yield: 30%, mp = oily, R f : 0.66 (hexane-diethyl ether 
4-(2,3-Dimethoxyphenyl)-6-(4-methoxylphenyl)pyrimidin-2-ol (31)
Yield: 36%, mp = oily, R f : 0. 
4-(2,5-Dimethoxyphenyl)-6-(4-methoxyphenyl)pyrimidin-2-ol (32)
Yield: 39%, mp = 186-188 
4-(2-Methoxyphenyl)-6-(2,3,4-trimethoxyphenyl)pyrimidin-2-ol (33)
Yield: 39%, mp = 152-154 
4-(4-Methoxyphenyl)-6-(2,3,4-trimethoxyphenyl)pyrimidin-2-ol (34)
Yield
3-[6-(4-Hydroxyphenyl)-2-mercaptopyrimidin-4-yl]phenol (38)
Yield: 39%, mp = oily, R f : 0. 398.17 (100).
4-(2,3-Dimethoxyphenyl)-6-(4-methoxyphenyl)pyrimidine-2-thiol (42)
Yield: 39%, mp = 113-115 
α -Glucosidase inhibition assay of compounds 20-44
The α -glucosidase inhibition assay was performed spectrophotometrically. α -Glucosidase from Saccharomyces cerevisiae (Sigma-Aldrich) was dissolved in phosphate buffer (pH 6.8, 50 mM). The test compounds were dissolved in DMSO. Next 20 µ L of the test sample, 20 µL of the enzyme (20 mU/mL), and 135 µ L of buffer were added to 96-well microtiter plates and incubated for 15 min at 37 • C. After incubation, 25 µ L of p -nitrophenyl-α -D-glucopyranoside (2 mM, Sigma-Aldrich) was added, and the change in absorbance was monitored for 30 min at 400 nm. The test compound was replaced by DMSO (7.5% final) as a control and acarbose (Sigma-Aldrich) was used as a standard inhibitor.
46−48
Antilipase activity assay of compounds 20-44
The inhibitory effects of the compounds were evaluated against porcine pancreatic lipase (PPL) (Applichem, Germany) (15 mg/mL). Lipase activity assays were performed as described in the literature. 62 Activity was measured using 4-methylumbelliferyl oleate (4-MU oleate) as a substrate. Briefly, compounds were mixed with Residual activities were calculated in comparison to a control without inhibitor. The assays were done in triplicate. IC 50 values were determined as the concentration of a compound giving 50% inhibition of maximal activity.
49,50,61
Antimicrobial activities of pyrimidine compounds (20-44)
The newly synthesized compounds were screened for their in vitro antibacterial activity against Escherichia coli ATCC35218, Yersinia pseudotuberculosis ATCC911, Pseudomonas aeruginosa ATCC43288, E. faecalis ATCC29212, S. aureus ATCC25923, B. cereus 709 Roma, Mycobacterium smegmatis ATCC607, Candida albicans ATCC60193, and Saccharomyces cerevisiae RSKK 251, all obtained from the Refik Saydam Hygiene Center (Ankara, Turkey). All tested compounds were dissolved in hexane and diluted with dimethyl sulfoxide (DMSO) to prepare 10.0 mg/mL solutions. The antimicrobial effects of the compounds were tested quantitatively in respective broth media using double dilution, and minimal inhibition concentration (MIC) values (µ g/mL) were determined. 51 The antibacterial and antifungal assays were performed in Mueller-Hinton broth (MH) (Difco, Detroit, MI, USA) at pH 7.3 and buffered yeast nitrogen base (Difco) at pH 7.0, respectively.
Brain-heart infusion broth (BHI) (Difco) was used for M. smegmatis. 52 The MIC was defined as the lowest concentration showing no growth. Ampicillin (10.0 mg/mL), streptomycin (10.0 mg/mL), and fluconazole (5.0 mg/mL) were used as standard antibacterial and antifungal drugs, respectively. DMSO at a dilution of 1:10 was used as solvent. The smallest concentration at which the growth of the test microorganism was totally inhibited is reported as the MIC (µg/mL) value (Table 3 ).
Conclusion
We have successfully developed an efficient and simple method for preparing a variety of new substituted 4,6-diarylpyrimidin cereus were within the range of 1.95-277.5 µ g/mL, 2.1-138.8 µ g/mL, and 1.95-19.1 µ g/mL, respectively. Of all the synthesized new pyrimidine derivatives, compounds 20, 21, 23, 24, 35, 36, 37, 38, and 39 were more active than the standard (streptomycin, 4 µ g/mL), and can be used as tuberculosis agents.
